IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery

• Status: Completed
• Trial end date: 2012-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Can Intraoperative systemic lidocaine decrease postoperative opioid consumption and improve quality of recovery after laparoscopic gastric bypass surgery? The hypotheses:does the use of intraoperative systemic lidocaine decrease postoperative opioid consumption and improve quality of recovery after laparoscopic gastric bypass surgery.

This study has the potential to confirm an opioid sparing strategy for morbid obese patients undergoing laparoscopic gastric bypass surgery. The high incidence of obstructive sleep apnea and the increased risk of postoperative hypoxemia make the development of opioid sparing techniques in this patient population warranted.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Northwestern University
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• ASA I, II,III;

• BMI > 35 kg/m2,

• Age between 18-70,

• Fluent in English,

• Patients undergoing laparoscopic gastric bypass,

• EKG within 3 months.

Exclusion Criteria:

• History of allergy to local anesthetics,

• History of chronic opioid use,

• Pregnant patients,

• History of EKG abnormalities.

Dropout: Conversion to open, patient or surgeon request.